KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
-3.05%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$498M
AUM Growth
+$498M
(-5.5%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.75%
Top 10 Holdings %
Top 10 Hldgs %
39.47%
Holding
120
New
1
Increased
23
Reduced
44
Closed
6
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$17.8M |
| 2 |
Medtronic
MDT
|
$612K |
| 3 |
NVIDIA
NVDA
|
$411K |
| 4 |
Coca-Cola
KO
|
$297K |
| 5 |
Edwards Lifesciences
EW
|
$281K |
Top Sells
| 1 |
Unilever
UL
|
$677K |
| 2 |
Apple
AAPL
|
$612K |
| 3 |
Ormat Technologies
ORA
|
$592K |
| 4 |
Automatic Data Processing
ADP
|
$568K |
| 5 |
Microsoft
MSFT
|
$337K |
Sector Composition
| 1 | Healthcare | 27.22% |
| 2 | Technology | 23.59% |
| 3 | Industrials | 12.68% |
| 4 | Consumer Discretionary | 8.33% |
| 5 | Consumer Staples | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Becton Dickinson
BDX
$53.9B
| $6.74M | 1.35% |
30,253
-675
| -2% | -$150K |
|
27
Chevron
CVX
$326B
| $6.21M | 1.25% |
43,235
-90
| -0.2% | -$12.9K |
|
28
PayPal
PYPL
$66.2B
| $6.03M | 1.21% |
70,035
+790
| +1% | +$68K |
|
29
Nike
NKE
$110B
| $5.99M | 1.2% |
71,998
+1,352
| +2% | +$112K |
|
30
PepsiCo
PEP
$206B
| $5.96M | 1.2% |
36,515
-110
| -0.3% | -$18K |
|
31
Illumina
ILMN
$15.8B
| $4.42M | 0.89% |
23,167
+193
| +0.8% | +$36.8K |
|
32
Exxon Mobil
XOM
$489B
| $4.3M | 0.86% |
49,260
-925
| -2% | -$80.8K |
|
|
33
Medtronic
MDT
$120B
| $4.27M | 0.86% |
52,923
+7,578
| +17% | +$612K |
|
|
34
NVIDIA
NVDA
$4.16T
| $4.11M | 0.83% |
33,856
+3,384
| +11% | +$411K |
|
|
35
Unilever
UL
$156B
| $2.81M | 0.56% |
64,062
-15,440
| -19% | -$677K |
|
36
iShares Core S&P 500 ETF
IVV
$657B
| $2.75M | 0.55% |
7,660
| – | – |
|
|
37
Edwards Lifesciences
EW
$47.8B
| $2.29M | 0.46% |
27,755
+3,405
| +14% | +$281K |
|
38
AbbVie
ABBV
$374B
| $2.22M | 0.45% |
16,562
-290
| -2% | -$38.9K |
|
39
Intel
INTC
$106B
| $2.14M | 0.43% |
82,891
-9,230
| -10% | -$238K |
|
40
Merck
MRK
$214B
| $2.02M | 0.41% |
23,438
-187
| -0.8% | -$16.1K |
|
41
Aptiv
APTV
$17.3B
| $1.85M | 0.37% |
23,640
-570
| -2% | -$44.6K |
|
42
Eli Lilly
LLY
$659B
| $1.79M | 0.36% |
5,526
-5
| -0.1% | -$1.62K |
|
|
43
Coca-Cola
KO
$297B
| $1.45M | 0.29% |
25,827
+5,300
| +26% | +$297K |
|
44
EOG Resources
EOG
$68.8B
| $1.35M | 0.27% |
12,112
-45
| -0.4% | -$5.03K |
|
45
Norfolk Southern
NSC
$62.4B
| $1.35M | 0.27% |
6,455
| – | – |
|
46
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.27M | 0.25% |
4,744
| – | – |
|
47
Novo Nordisk
NVO
$251B
| $1.24M | 0.25% |
12,432
-480
| -4% | -$47.8K |
|
48
Visa
V
$679B
| $1.24M | 0.25% |
6,976
| – | – |
|
49
Colgate-Palmolive
CL
$67.9B
| $1.13M | 0.23% |
16,022
-820
| -5% | -$57.6K |
|
50
General Mills
GIS
$26.4B
| $1.04M | 0.21% |
13,525
-1,050
| -7% | -$80.4K |
|